Intermediate Density Lipoproteins (IDL)
Catalog Number: B2014467 (1 mg)
Intermediate Density Lipoproteins (IDL) is a high quality IDL purified from Human Plasma. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Intermediate Density Lipoproteins (IDL)
Catalog number: B2014467
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: 5-10,000,000 Da
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: 2 to 8°C
Keywords: Lipoproteins, Intermediate Density, Human Plasma
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Lei D, Yu Y, Kuang YL, Liu J, Krauss RM, Ren G. Single-molecule 3D imaging of human plasma intermediate-density lipoproteins reveals a polyhedral structure Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):260-270.
2: Musliner TA, McVicker KM, Iosefa JF, Krauss RM. Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat Arteriosclerosis. 1987 Jul-Aug;7(4):408-20.
3: Dupras R, Brissette L, Roach PD, Bégin S, Tremblay A, Noël SP. The disappearance rate of human versus rat intermediate density lipoproteins from rat liver perfusion Biochem Cell Biol. 1991 Aug;69(8):537-43.
4: Friedman G, Gavish D, Vogel T, Eisenberg S. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL) Biochim Biophys Acta. 1990 May 1;1044(1):118-26.
5: Kwakernaak AJ, Lambert G, Dullaart RP. Plasma proprotein convertase subtilisin-kexin type 9 is predominantly related to intermediate density lipoproteins Clin Biochem. 2014 May;47(7-8):679-82.
6: Michell DL, Vickers KC. Lipoprotein carriers of microRNAs Biochim Biophys Acta. 2016 Dec;1861(12 Pt B):2069-2074.
7: Nordestgaard BG, Tybjaerg-Hansen A, Lewis B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants Arterioscler Thromb. 1992 Jan;12(1):6-18.
8: Singh S, Zahoor I, Sharma N, Behl T, Kanojia N, Sehgal A, Mohan S, Almoshari Y, Salawi A, Aleya L, Bungau S. Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia Environ Sci Pollut Res Int. 2022 Nov;29(51):76514-76531.
9: Lavallée B, Provost PR, Belanger A. Formation of pregnenolone- and dehydroepiandrosterone-fatty acid esters by lecithin-cholesterol acyltransferase in human plasma high density lipoproteins Biochim Biophys Acta. 1996 Feb 16;1299(3):306-12.
10: Dzien A, Breier C, Lisch HJ, Braunsteiner H. Stimulating effect of intermediate-density lipoproteins (IDL) from hyperlipemic plasma on hepatic lipase Klin Wochenschr. 1986 Jun 2;64(11):530-3.
Products Related to Intermediate Density Lipoproteins (IDL) can be found at Proteins
Additional Information
Weight | 48 oz |
---|---|
Dimensions | 8 × 8 × 8 in |